NTPDase1 controls IL-8 production by human neutrophils

Journal of Immunology

Volumn 187, Issue 2, 2011, Pages 644-653

  Kukulski, Filip ^a,b   Bahrami, Fariborz ^a,b   Ben Yebdri, Fethia ^a,b   Lecka, Joanna ^a,b   Martín Satué, Mireia ^a,b   Lévesque, Sébastien A ^a,b   Sévigny, Jean ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ECTONUCLEOTIDASE NTPDASE1; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 2; NUCLEOTIDASE; PURINERGIC P2Y2 RECEPTOR; UNCLASSIFIED DRUG;

ANTIBODY LABELING; ARTICLE; CELL STIMULATION; CELL STRAIN HL 60; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME ACTIVITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HYDROLYSIS; NEUTROPHIL; PRIORITY JOURNAL; RNA INTERFERENCE;

EID: 79960507785     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002680     Document Type: Article

References (55)

1. Nathan, C. 2006. Neutrophils and immunity: challenges and opportunities. Nat. Rev. Immunol. 6: 173-182.
2. Nauseef, W. M. 2007. How human neutrophils kill and degrade microbes: an integrated view. Immunol. Rev. 219: 88-102.
3. Bours, M. J., E. L. Swennen, F. Di Virgilio, B. N. Cronstein, and P. C. Dagnelie. 2006. Adenosine 59-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol. Ther. 112: 358-404.
4. Jin, J. G., V. R. Dasari, F. D. Sistare, and S. P. Kunapuli. 1998. Distribution of P2Y receptor subtypes on haematopoietic cells. Br. J. Pharmacol. 123: 789-794.
5. Chen, Y., R. Corriden, Y. Inoue, L. Yip, N. Hashiguchi, A. Zinkernagel, V. Nizet, P. A. Insel, and W. G. Junger. 2006. ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors. Science 314: 1792-1795.
6. Abbracchio, M. P., G. Burnstock, J. M. Boeynaems, E. A. Barnard, J. L. Boyer, C. Kennedy, G. E. Knight, M. Fumagalli, C. Gachet, K. A. Jacobson, and G. A.Weisman. 2006. International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol. Rev. 58: 281-341.
7. 2 receptor. Am. J. Physiol. Cell Physiol. 286: C264-C271.
8. Junger, W. G. 2008. Purinergic regulation of neutrophil chemotaxis. Cell. Mol. Life Sci. 65: 2528-2540.
9. Kukulski, F., F. Ben Yebdri, J. Lecka, G. Kauffenstein, S. A. Lévesque, M. Martín-Satué, and J. Sévigny. 2009. Extracellular ATP and P2 receptors are required for IL-8 to induce neutrophil migration. Cytokine 46: 166-170.
10. Balazovich, K. J., and L. A. Boxer. 1990. Extracellular adenosine nucleotides stimulate protein kinase C activity and human neutrophil activation. J. Immunol. 144: 631-637.
11. Cockcroft, S., and J. Stutchfield. 1989. ATP stimulates secretion in human neutrophils and HL60 cells via a pertussis toxin-sensitive guanine nucleotide-binding protein coupled to phospholipase C. FEBS Lett. 245: 25-29. (Pubitemid 19076199)
12. Ward, P. A., T. W. Cunningham, K. K. McCulloch, and K. J. Johnson. 1988. Regulatory effects of adenosine and adenine nucleotides on oxygen radical responses of neutrophils. Lab. Invest. 58: 438-447.
13. Kuroki, M., and S. Minakami. 1989. Extracellular ATP triggers superoxide production in human neutrophils. Biochem. Biophys. Res. Commun. 162: 377-380.
14. 2 receptors control the recruitment of neutrophils to the lungs in a mouse model of sepsis. Shock 30: 173-177.
15. Eltzschig, H. K., T. Eckle, A. Mager, N. Küper, C. Karcher, T. Weissmüller, K. Boengler, R. Schulz, S. C. Robson, and S. P. Colgan. 2006. ATP release from activated neutrophils occurs via connexin 43 and modulates adenosinedependent endothelial cell function. Circ. Res. 99: 1100-1108.
16. Corriden, R., Y. Chen, Y. Inoue, G. Beldi, S. C. Robson, P. A. Insel, and W. G. Junger. 2008. Ecto-nucleoside triphosphate diphosphohydrolase 1 (E-NTPDase1/CD39) regulates neutrophil chemotaxis by hydrolyzing released ATP to adenosine. J. Biol. Chem. 283: 28480-28486.
17. Kukulski, F., S. A. Lévesque, E. G. Lavoie, J. Lecka, F. Bigonnesse, A. F. Knowles, S. C. Robson, T. L. Kirley, and J. Sévigny. 2005. Comparative hydrolysis of P2 receptor agonists by NTPDases 1, 2, 3 and 8. Purinergic Signal. 1: 193-204.
18. Fausther, M., and J. Sévigny. 2011. Extracellular nucleosides and nucleotides regulate liver functions via a complex system of membrane proteins. C. R. Biol. 334: 100-117.
19. Deaglio, S., and S. C. Robson. 2011. Ectonucleotidases as regulators of purinergic signaling in thrombosis, inflammation and immunity. Adv. Pharmacol. 61: 301-332.
20. Kukulski, F., S. A. Lévesque, and J. Sévigny. 2011. Impact of ectoenzymes on P2 and P1 receptor signaling. Adv. Pharmacol. 61: 263-299.
21. Eltzschig, H. K., L. F. Thompson, J. Karhausen, R. J. Cotta, J. C. Ibla, S. C. Robson, and S. P. Colgan. 2004. Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism. Blood 104: 3986-3992.
22. Reutershan, J., I. Vollmer, S. Stark, R. Wagner, K. C. Ngamsri, and H. K. Eltzschig. 2009. Adenosine and inflammation: CD39 and CD73 are critical mediators in LPS-induced PMN trafficking into the lungs. FASEB J. 23: 473-482.
23. Friedman, D. J., B. M. Kunzli, Y. I. A-Rahim, J. Sévigny, P. O. Berberat, K. Enjyoji, E. Csizmadia, H. Friess, and S. C. Robson. 2009. From the cover: CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease. Proc. Natl. Acad. Sci. USA 106: 16788-16793.
24. Wagner, J. G., and R. A. Roth. 2000. Neutrophil migration mechanisms, with an emphasis on the pulmonary vasculature. Pharmacol. Rev. 52: 349-374.
25. Gabel, C. A. 2007. P2 purinergic receptor modulation of cytokine production. Purinergic Signal. 3: 27-38.
26. Li, A., M. L. Varney, J. Valasek, M. Godfrey, B. J. Dave, and R. K. Singh. 2005. Autocrine role of interleukin-8 in induction of endothelial cell proliferation, survival, migration and MMP-2 production and angiogenesis. Angiogenesis 8: 63-71.
27. Kurt-Jones, E. A., L. Mandell, C. Whitney, A. Padgett, K. Gosselin, P. E. Newburger, and R. W. Finberg. 2002. Role of toll-like receptor 2 (TLR2) in neutrophil activation: GM-CSF enhances TLR2 expression and TLR2-mediated interleukin 8 responses in neutrophils. Blood 100: 1860-1868.
28. Kukulski, F., F. Ben Yebdri, J. Lefebvre, M. Warny, P. A. Tessier, and J. Sévigny. 2007. Extracellular nucleotides mediate LPS-induced neutrophil migration in vitro and in vivo. J. Leukoc. Biol. 81: 1269-1275.
29. Bauer, S., T. Müller, and S. Hamm. 2009. Pattern recognition by Toll-like receptors. Adv. Exp. Med. Biol. 653: 15-34.
30. Chakravarti, A., M. A. Raquil, P. Tessier, and P. E. Poubelle. 2009. Surface RANKL of Toll-like receptor 4-stimulated human neutrophils activates osteoclastic bone resorption. Blood 114: 1633-1644.
31. Collins, S. J., F. W. Ruscetti, R. E. Gallagher, and R. C. Gallo. 1979. Normal functional characteristics of cultured human promyelocytic leukemia cells (HL-60) after induction of differentiation by dimethylsulfoxide. J. Exp. Med. 149: 969-974.
32. Baykov, A. A., O. A. Evtushenko, and S. M. Avaeva. 1988. A malachite green procedure for orthophosphate determination and its use in alkaline phosphatase-based enzyme immunoassay. Anal. Biochem. 171: 266-270.
33. Munkonda, M. N., G. Kauffenstein, F. Kukulski, S. A. Lévesque, C. Legendre, J. Pelletier, E. G. Lavoie, J. Lecka, and J. Sévigny. 2007. Inhibition of human and mouse plasma membrane bound NTPDases by P2 receptor antagonists. Biochem. Pharmacol. 74: 1524-1534.
34. Pulte, E. D., M. J. Broekman, K. E. Olson, J. H. Drosopoulos, J. R. Kizer, N. Islam, and A. J. Marcus. 2007. CD39/NTPDase-1 activity and expression in normal leukocytes. Thromb. Res. 121: 309-317.
35. Hayashi, F., T. K. Means, and A. D. Luster. 2003. Toll-like receptors stimulate human neutrophil function. Blood 102: 2660-2669.
36. Koller, B., M. Kappler, P. Latzin, A. Gaggar, M. Schreiner, S. Takyar, M. Kormann, M. Kabesch, D. Roos, M. Griese, and D. Hartl. 2008. TLR expression on neutrophils at the pulmonary site of infection: TLR1/TLR2-mediated up-regulation of TLR5 expression in cystic fibrosis lung disease. J. Immunol. 181: 2753-2763.
37. Lévesque, S. A., E. G. Lavoie, J. Lecka, F. Bigonnesse, and J. Sévigny. 2007. Specificity of the ecto-ATPase inhibitor ARL 67156 on human and mouse ectonucleotidases. Br. J. Pharmacol. 152: 141-150.
38. Müller, C. E. 2002. P2-pyrimidinergic receptors and their ligands. Curr. Pharm. Des. 8: 2353-2369.
39. Rettinger, J., K. Braun, H. Hochmann, M. U. Kassack, H. Ullmann, P. Nickel, G. Schmalzing, and G. Lambrecht. 2005. Profiling at recombinant homomeric and heteromeric rat P2X receptors identifies the suramin analogue NF449 as a highly potent P2X1 receptor antagonist. Neuropharmacology 48: 461-468. (Pubitemid 40250009)
40. 6 receptors on monocytes is required for TLR1/2-induced neutrophil migration by regulating IL-8 secretion. Eur. J. Immunol. 39: 2885-2894.
41. Kukulski, F., F. Ben Yebdri, F. Bahrami, S. A. Lévesque, M. Martín-Satué, and J. Sévigny. 2010. The P2 receptor antagonist PPADS abrogates LPS-induced neutrophil migration in the murine air pouch via inhibition of MIP-2 and KC production. Mol. Immunol. 47: 833-839.
42. Vandal, K., P. Rouleau, A. Boivin, C. Ryckman, M. Talbot, and P. A. Tessier. 2003. Blockade of S100A8 and S100A9 suppresses neutrophil migration in response to lipopolysaccharide. J. Immunol. 171: 2602-2609.
43. Imai, M., C. Goepfert, E. Kaczmarek, and S. C. Robson. 2000. CD39 modulates IL-1 release from activated endothelial cells. Biochem. Biophys. Res. Commun. 270: 272-278.
44. Ferrari, D., P. Chiozzi, S. Falzoni, S. Hanau, and F. Di Virgilio. 1997. Purinergic modulation of interleukin-1-beta release from microglial cells stimulated with bacterial endotoxin. J. Exp. Med. 185: 579-582.
45. Lévesque, S. A., F. Kukulski, K. Enjyoji, S. C. Robson, and J. Sévigny. 2010. NTPDase1 governs P2X7-dependent functions in murine macrophages. Eur. J. Immunol. 40: 1473-1485.
46. Grimm, M. C., S. K. Elsbury, P. Pavli, and W. F. Doe. 1996. Interleukin 8: cells of origin in inflammatory bowel disease. Gut 38: 90-98.
47. Zimmerman, N. P., R. A. Vongsa, M. K. Wendt, and M. B. Dwinell. 2008. Chemokines and chemokine receptors in mucosal homeostasis at the intestinal epithelial barrier in inflammatory bowel disease. Inflamm. Bowel Dis. 14: 1000-1011.
48. Eltzschig, H. K., J. C. Ibla, G. T. Furuta, M. O. Leonard, K. A. Jacobson, K. Enjyoji, S. C. Robson, and S. P. Colgan. 2003. Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors. J. Exp. Med. 198: 783-796.
49. Grenz, A., H. Zhang, M. Hermes, T. Eckle, K. Klingel, D. Y. Huang, C. E. Müller, S. C. Robson, H. Osswald, and H. K. Eltzschig. 2007. Contribution of E-NTPDase1 (CD39) to renal protection from ischemia-reperfusion injury. FASEB J. 21: 2863-2873.
50. Köhler, D., T. Eckle, M. Faigle, A. Grenz, M. Mittelbronn, S. Laucher, M. L. Hart, S. C. Robson, C. E. Müller, and H. K. Eltzschig. 2007. CD39/ectonucleoside triphosphate diphosphohydrolase 1 provides myocardial protection during cardiac ischemia/reperfusion injury. Circulation 116: 1784-1794.
51. Eltzschig, H. K., D. Köhler, T. Eckle, T. Kong, S. C. Robson, and S. P. Colgan. 2009. Central role of Sp1-regulated CD39 in hypoxia/ischemia protection. Blood 113: 224-232.
52. Hyman, M. C., D. Petrovic-Djergovic, S. H. Visovatti, H. Liao, S. Yanamadala, D. Bou?̈s, E. J. Su, D. A. Lawrence, M. J. Broekman, A. J. Marcus, and D. J. Pinsky. 2009. Self-regulation of inflammatory cell trafficking in mice by the leukocyte surface apyrase CD39. J. Clin. Invest. 119: 1136-1149.
53. Chen, Y., A. Shukla, S. Namiki, P. A. Insel, and W. G. Junger. 2004. A putative osmoreceptor system that controls neutrophil function through the release of ATP, its conversion to adenosine, and activation of A2 adenosine and P2 receptors. J. Leukoc. Biol. 76: 245-253.
54. Robson, S. C., E. Kaczmarek, J. B. Siegel, D. Candinas, K. Koziak, M. Millan, W. W. Hancock, and F. H. Bach. 1997. Loss of ATP diphosphohydrolase activity with endothelial cell activation. J. Exp. Med. 185: 153-163.
55. Krötz, F., H. Y. Sohn, M. Keller, T. Gloe, S. S. Bolz, B. F. Becker, and U. Pohl. 2002. Depolarization of endothelial cells enhances platelet aggregation through oxidative inactivation of endothelial NTPDase. Arterioscler. Thromb. Vasc. Biol. 22: 2003-2009.